Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer
- Conditions
- Rectal Cancer
- Interventions
- Other: blood sampels from vena rectalis superior and vena cubiti
- Registration Number
- NCT01706809
- Lead Sponsor
- Odense University Hospital
- Brief Summary
The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.
- Detailed Description
Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative and after 3 month peripheral blood samples is collected.
A total of 50 patients will be included in this study.
The study is approved by the local scientific ethical committee No. S-20100006
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Histological verified cancer
- The cancer must be located in rectum maximum of 15 cm.
- Age above 18
Read More
Exclusion Criteria
- Disseminated cancer
- Perioperative radio-chemotherapy
- Laparoscopy surgery
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Biomarkeres blood sampels from vena rectalis superior and vena cubiti -
- Primary Outcome Measures
Name Time Method The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival. after the study is complete
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Vejle hospital
🇩🇰Vejle, Denmark